anonymous
Guest
anonymous
Guest
Well, I guess when you are unethical and do bad things, bad things may come back and bite you in the ass. For the new leaders at Dendreon this possibly comes in the form of the new Trump executive order to limit part B drug prices. If you look at the drugs that this policy has analyzed, Provenge is the most expensive drug on that list! Dendreon's only hope is that CMS looks at the overall spend and takes a pass. If not, then my guess is that not alot of private practice groups are going to take the risk of shelling out tens of thousands of dollars if they only make a couple hundred. And don't expect Biden to reverse it; American people are tired of paying more for their drugs and this will be a popular policy change.
Ain't Karma a bitch you ex-Mallinckrodt fools!?
One more reason to NOT come to work for this company. The $200K+ they promise you won't hold up very long if nobody is buying the product anymore.
Ain't Karma a bitch you ex-Mallinckrodt fools!?
One more reason to NOT come to work for this company. The $200K+ they promise you won't hold up very long if nobody is buying the product anymore.